Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 395

1.

A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.

Romach MK, Kaplan HL, Busto UE, Somer G, Sellers EM.

J Clin Psychopharmacol. 1998 Apr;18(2):121-31.

PMID:
9555597
2.

[Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].

Lemoine P, Touchon J, Billardon M.

Encephale. 1997 Jul-Aug;23(4):290-9. French.

PMID:
9417395
3.

Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.

Small GW, Bystritsky A.

J Clin Psychiatry. 1997;58 Suppl 11:24-9.

PMID:
9363045
4.

A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.

Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.

J Clin Psychopharmacol. 1993 Dec;13(6):429-37.

PMID:
7907097
5.

A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms.

Lader M, Farr I, Morton S.

Int Clin Psychopharmacol. 1993 Spring;8(1):31-6.

PMID:
8097214
6.

Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.

Busto UE, Naranjo CA, Bremner KE, Peachey JE, Bologa M.

J Psychiatry Neurosci. 1998 Jan;23(1):35-44.

7.

Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder.

Mandos LA, Rickels K, Cutler N, Roeschen J, Keppel Hesselink JM, Schweizer E.

Int Clin Psychopharmacol. 1995 Nov;10(4):251-6.

PMID:
8748047
8.

Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.

Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG.

J Clin Psychiatry. 1997;58 Suppl 11:19-23.

PMID:
9363044
9.

The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.

Mercier-Guyon C, Chabannes JP, Saviuc P.

Curr Med Res Opin. 2004 Sep;20(9):1347-55.

PMID:
15383182
10.
11.
12.

Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.

Cohn JB, Wilcox CS.

Pharmacotherapy. 1984 Mar-Apr;4(2):93-8.

PMID:
6144090
13.

Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.

Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, Barnhill J.

J Clin Psychopharmacol. 2006 Oct;26(5):519-23.

PMID:
16974197
14.

Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome.

Rickels K, Schweizer E, Garcia España F, Case G, DeMartinis N, Greenblatt D.

Psychopharmacology (Berl). 1999 Jan;141(1):1-5.

PMID:
9952057
15.

Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial.

Petrovic M, Pevernagie D, Mariman A, Van Maele G, Afschrift M.

Eur J Clin Pharmacol. 2002 Jan;57(11):759-64.

PMID:
11868796
16.

Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.

Rickels K, Schweizer E, DeMartinis N, Mandos L, Mercer C.

J Clin Psychopharmacol. 1997 Aug;17(4):272-7.

PMID:
9241006
17.

Changes in "withdrawal symptoms" following discontinuation of low-dose diazepam.

Hayward P, Wardle J, Higgitt A, Gray J.

Psychopharmacology (Berl). 1996 Jun;125(4):392-7.

PMID:
8826545
19.

[The anxiolytic effect of ondansetron and its capacity to eliminate the benzodiazepine abstinence syndrome in rats].

Garibova TL, Voronina TA, Kraĭneva VA, Val'dman EA.

Eksp Klin Farmakol. 1999 Nov-Dec;62(6):16-9. Russian.

PMID:
10650519
20.

Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program.

Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, Mulder J, van de Lisdonk EH, Breteler MH, Zitman FG.

Can J Psychiatry. 2006 Jun;51(7):445-52.

PMID:
16838826
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk